Search

Author/Creator Martinsson, T.

1. Novel human-derived EML4-ALK fusion cell lines identify ribonucleotide reductase RRM2 as a target of activated ALK in NSCLC. (September 2022)

Authors:
Bokhari, A.A.; Lai, W-Y.; Le, A.T.; Gabre, J.L.; Chuang, T-P.; Fransson, S.; Bergman, B.; Djos, A.; Chen, N.; Martinsson, T.; Van den Eynden, J.; Doebele, R.C.; Palmer, R.H.; Hallberg, B.; Umapathy, G.
Journal:
Lung cancer
Issue:
Volume 171(2022)
Page Start:
103
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search